PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Tabula Rasa HealthCare

Press Release

Share      Blog

Receive press releases from Tabula Rasa HealthCare: By Email PDF Version RSS Feeds:

Tabula Rasa HealthCare Responds to CMS Announcement of Part D Enhanced Medication Therapy Managment Model


Under the CMS Enhanced MTM Model, the personalized MTM services offered by Tabula Rasa HealthCare are now eligible for reimbursement by CMS, and for additional performance-based payments. TRHC's Medication Risk Mitigation Matrix(TM) has proven to reduce adverse drug reactions.

Moorestown, NJ, October 29, 2015 --(PR.com)-- The Centers for Medicare & Medicaid Services (CMS) recently announced a new program, providing financial incentives and regulatory flexibility to certain Part D Prescription Drug Plans (PDPs), to encourage meaningful innovation in Medication Therapy Management (MTM) services.

CMS calls its new program the “Enhanced MTM Model.”

“Long before the CMS announcement, Tabula Rasa HealthCare (TRHC) has been providing PDPs with its MedWise Advisor® application for personalized MTM services,” said Brian Litten, TRHC Chief Strategy Officer. “Under the CMS Enhanced MTM Model, however, the personalized MTM services offered by TRHC are now eligible for reimbursement by CMS – and for additional performance-based payments.”

MedWise Advisor® (MWA) is a cloud-based medication safety platform. Rather than relying on single drug-to-drug interaction analysis, which is the prevailing non-personalized approach of medication safety software programs, MWA uses a proprietary, technology-based system designed by clinicians and academics. It combines clinical and pharmacology data, population-based algorithms and extensive patient-specific data, including medical history, lab results, medication lists and personal genomic information, to optimize medication regimens to improve patient outcomes.

According to TRHC Chairman and CEO Dr. Calvin H. Knowlton, “Our Medication Risk Mitigation Matrix™ (Pat. Pending), which lies at the heart of MWA, has been proven to reduce medication-related problems (especially adverse drug reactions), falls, hospitalizations, and hospital readmissions – and to improve overall quality of care and reduce costs.”

Please see www.enhancedmtm.com for more information.

Litten will be speaking at the MTM Summit November 13, 2015: “PDPs interested in participating with TRHC are welcome to contact me directly,” offered Litten.

About Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s leading offering, and its cloud-based software applications, including EireneRx and MedWise Advisor, provide solutions for a range of payers, providers and other healthcare organizations. www.tabularasahealthcare.com
Contact Information
Tabula Rasa Heallthcare
Dianne Semingson
215-870-0829
Contact
tabularasahealthcare.com
Orsula Knowlton, TRHC
215-680-8983

Click here to view the list of recent Press Releases from Tabula Rasa HealthCare
Promote Your Business